SCP-8891
Safe
~
medium confidence
SCP-8891
Expected annual
$21.4M
One-time setup
$263.0M
Annual recurring
$9.3M
Personnel
20
One-time containment/treatment infrastructure and an aggressive mass surgical campaign drive extremely high up-front costs (~$263,000,000 one-time); routine monitoring, case management, and limited medical care drive ongoing costs (~$9,300,000/yr). Primary drivers: R&D and lab setup, potential mass surgical campaign, long-term care and monitoring.
One-Time Capital Costs
Total: $263.0M
Annual Recurring Costs
Total: $9.3M/yr
Cost Scenarios
📊
Baseline
(baseline)
$9.3M/yr
Normal year with monitoring/suppression posture and limited Foundation custody; no mass remediation campaign.
routine_monitoring
periodic_hospitalizations
no_mass_remediation
🚨
Major Incident
$11.8M/yr
Localized cluster of severe complications, hospitalizations, or limited public exposure requiring emergency activations and extra legal/medical costs.
widespread_infection
cluster_hospitalizations
limited_media_exposure
🚨
Aggressive Remediation
$249.6M/yr
Authorized R&D + mass surgical/remediation campaign year: large one-time R&D and surgery expenditures plus elevated recurring operational tempo.
project_Jiangshi_scaleup
mass_surgical_campaign
large_scale_manufacturing
Personnel
20 total
| Role | Count | Notes |
|---|---|---|
| Case Manager / Social Worker | 12 | [#1] Primary welfare & case-management staff represented in staff_wages estimate. |
| 24/7 Hotline Operator | 4 | [#1] Round-the-clock phone-line operators for remote check-ins and incident triage. |
| Administrative Staff / Record Keeper | 2 | [#1] Medical records, amnestic tracking and scheduling support. |
| Program Director / Compliance Officer | 1 | [#22] Program leadership and liaison included in staff_wages. |
| Finance / Procurement Administrator | 1 | [#22] Small administrative support for contracting and budgeting included in staff_wages. |
Confidence Notes
Cost ranges are broad and driven by technical uncertainty (ease of reproducing toolkit, per-patient surgical feasibility), litigation risk, and policy choices (suppression vs active remediation). Many line items are estimates from analyst ranges rather than fixed vendor quotes, so confidence is medium.